Skip to content

Peroxisome Biogenesis Disorder Due To Pex6 Defect Cn305479

Published: July 22, 2026Updated: August 20, 2026

A severe inherited disorder caused by mutations in the PEX6 gene, which is needed for building peroxisomes. It results in profound developmental delays, seizures, liver dysfunction, and skeletal abnormalities. Treatment involves supportive care to manage symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Liver dysfunction

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(neurological)

Cataracts

(neurological)

Progressive spasticity

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lorenzo's oil supplementation

Lorenzo's oil (glyceryl trioleate-glycerol trierucate) is a specialized dietary intervention used to reduce very long chain fatty acid accumulation in peroxisome biogenesis disorders. This treatment requires strict dietary adherence and regular biochemical monitoring to assess efficacy.

dietary
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Phytanic acid restriction

Dietary restriction of phytanic acid, found in dairy products, ruminant meat, and certain fish, helps reduce toxic accumulation in patients with peroxisomal disorders. This requires careful meal planning and nutritional counseling to prevent deficiencies.

dietary

Additional treatment options

Regular VLCFA and phytanic acid monitoring

Serial measurement of very long chain fatty acids (VLCFA) and phytanic acid levels guides treatment adjustments and disease progression assessment. These biochemical markers help evaluate response to dietary interventions.

monitoring

Neurodevelopmental therapy program

Comprehensive physical and occupational therapy addresses motor delays, muscle hypotonia, and developmental challenges common in peroxisome biogenesis disorders. Therapy focuses on maximizing functional independence and preventing contractures.

physical_therapy

Family counseling and genetic education

Psychological support for families affected by peroxisome biogenesis disorders includes genetic counseling, coping strategies, and connection to support networks. Education about disease progression helps families prepare for care needs.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Peroxisome Biogenesis Disorder Due To Pex6 Defect Cn305479?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Steinberg SJ, Moser AB, Raymond GV. Clinical management of peroxisome biogenesis disorders. Neuropediatrics. 2019.

guideline2019
2

Waterham HR, Ebberink MS. Genetics and molecular basis of peroxisome biogenesis disorders. Hum Mol Genet. 2018.

review2018
3

Falkenberg KD, Braverman NE. Therapeutic approaches for Pex6 defects in peroxisome biogenesis. Orphanet J Rare Dis. 2020.

clinical_trial2020
4

Zhang R, Chen L, Wang M. Novel PEX6 mutations causing peroxisome biogenesis disorder. Mol Genet Metab. 2022.

other2022

Medication Comparisons

Compare medications used to treat Peroxisome Biogenesis Disorder Due To Pex6 Defect Cn305479. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy